Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$98.98 - $115.74 $128,476 - $150,230
-1,298 Reduced 31.52%
2,820 $326,000
Q2 2023

Aug 07, 2023

BUY
$96.34 - $112.38 $396,728 - $462,780
4,118 New
4,118 $423,000
Q4 2022

Feb 13, 2023

BUY
$62.39 - $113.8 $118,353 - $215,878
1,897 New
1,897 $215,000
Q2 2022

Aug 09, 2022

BUY
$79.4 - $116.36 $3.12 Million - $4.57 Million
39,271 Added 260.75%
54,332 $4.33 Million
Q1 2022

May 12, 2022

BUY
$86.42 - $109.81 $1.3 Million - $1.65 Million
15,061 New
15,061 $1.59 Million
Q4 2021

Feb 10, 2022

SELL
$98.56 - $119.91 $282,670 - $343,901
-2,868 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $56,984 - $68,429
620 Added 27.58%
2,868 $314,000
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $193,867 - $215,628
2,248 New
2,248 $211,000
Q4 2020

Feb 12, 2021

SELL
$67.0 - $84.39 $520,322 - $655,372
-7,766 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $428,916 - $620,736
7,766 New
7,766 $603,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.